326
Views
11
CrossRef citations to date
0
Altmetric
Original

EPOETIN TREATMENT IMPROVES RED BLOOD CELL AND PLASMA ANTIOXIDANT CAPACITY IN HEMODIALYSIS PATIENTS

, M.D. Ph.D., , M.D. Ph.D. & , M.D. Ph.D.
Pages 77-87 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sultan Ozkurt, Fatma Ozenc, Nevbahar Akcar Degirmenci, Gokhan Temiz, Ahmet Musmul, Garip Sahin & Ahmet Ugur Yalcin. (2012) Acute and Subacute Effects of EV Iron Sucrose on Endothelial Functions in Hemodialysis Patients. Renal Failure 34:1, pages 1-6.
Read now
Jasmina Mimić-Oka, A. Savić-Radojević, M. Plješa-Ercegovac, M. Opačić, T. Simić, N. Dimković & D. V. Simić. (2005) Evaluation of Oxidative Stress after Repeated Intravenous Iron Supplementation. Renal Failure 27:3, pages 345-351.
Read now

Articles from other publishers (9)

Jina Lim, Chung Jo Yu, Hoon Yu & Sang Jin Ha. (2021) Erythropoietin therapy improves endothelial function in patients with non-dialysis chronic kidney disease and anemia (EARNEST-CKD). Medicine 100:42, pages e27601.
Crossref
Sara Bianchi, Jonathan Fusi, Ferdinando Franzoni, Luca Giovannini, Fabio Galetta, Claudio Mannari, Emanuele Guidotti, Leonardo Tocchini & Gino Santoro. (2016) “Effects of recombinant human erythropoietin high mimicking abuse doses on oxidative stress processes in rats”. Biomedicine & Pharmacotherapy 82, pages 355-363.
Crossref
Hong-Tao Tie, Ming-Zhu Luo, Dan Lin, Min Zhang, Jing-Yuan Wan & Qing-Chen Wu. (2015) Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. European Journal of Cardio-Thoracic Surgery 48:1, pages 32-39.
Crossref
Adis Tasanarong, Soodkate Duangchana, Sangduen Sumransurp, Boonlawat Homvises & Opas Satdhabudha. (2013) Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrology 14:1.
Crossref
Jacek Rysz. (2013) Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease. Medical Science Monitor 19, pages 954-959.
Crossref
Fatih Albayrak, Fehmi Odabasoglu, Zekai Halici, Beyzagul Polat, Hakan Dursun, Abdullah Uyanik, Yasin Bayir, Feride Koc, Halis Suleyman & Yavuz Albayrak. (2010) The role of erythropoietin in the protection of gastric mucosa from indometacin-induced gastric injury and its relationship with oxidant and antioxidant parameters in rats. Journal of Pharmacy and Pharmacology 62:1, pages 85-90.
Crossref
P. Katavetin, K. Tungsanga, S. Eiam-Ong & M. Nangaku. (2007) Antioxidative effects of erythropoietin. Kidney International 72, pages S10-S15.
Crossref
Kim E. Jie, Marianne C. Verhaar, Maarten-Jan M. Cramer, Karien van der Putten, Carlo A. J. M. Gaillard, Pieter A. Doevendans, Hein A. Koomans, Jaap A. Joles & Branko Braam. (2006) Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. American Journal of Physiology-Renal Physiology 291:5, pages F932-F944.
Crossref
Kazunobu Yoshimura, Hirofumi Nakano, Keitaro Yokoyama & Masaaki Nakayama. (2005) High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis. Clinical and Experimental Nephrology 9:2, pages 158-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.